BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37120317)

  • 1. How to handle brain tumors after esophagectomy with curative intent: A single center 20-year experience.
    Vanstraelen S; Depypere L; Moons J; Mandeville Y; Van Veer H; Lerut T; Coosemans W; Nafteux P
    Eur J Surg Oncol; 2023 Sep; 49(9):106916. PubMed ID: 37120317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent.
    Parry K; Visser E; van Rossum PS; Mohammad NH; Ruurda JP; van Hillegersberg R
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1292-300. PubMed ID: 26334295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curative treatment for esophageal cancer: Vancouver Island Cancer Centre experience from 1993 to 1998.
    Wilson KS; Wilson AG; Dewar GJ
    Can J Gastroenterol; 2002 Jun; 16(6):361-8. PubMed ID: 12096299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliative esophagectomy in unexpected metastatic disease: sense or nonsense?
    Depypere LP; Moons J; Lerut TE; Coosemans W; Van Veer H; Nafteux PR
    Asian Cardiovasc Thorac Ann; 2018 Sep; 26(7):552-557. PubMed ID: 30185072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns and Outcomes of Recurrent Esophageal Cancer After Curative Esophagectomy.
    Yamashita K; Watanabe M; Mine S; Kurogochi T; Okamura A; Hayami M; Imamura Y
    World J Surg; 2017 Sep; 41(9):2337-2344. PubMed ID: 28432391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abandoning resectional intent in patients initially deemed suitable for esophagectomy: a nationwide study of risk factors and outcomes.
    Edholm D; Lindblad M; Linder G
    Dis Esophagus; 2021 Mar; 34(3):. PubMed ID: 32960273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Survival After Treatment of Oligometastases After Esophagectomy.
    Ghaly G; Harrison S; Kamel MK; Rahouma M; Nasar A; Port JL; Stiles BM; Altorki NK
    Ann Thorac Surg; 2018 Feb; 105(2):357-362. PubMed ID: 29275824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
    Zou B; Tu Y; Liao D; Xu Y; Wang J; Huang M; Ren L; Zhu J; Gong Y; Liu Y; Zhou L; Zhou X; Peng F; Lu Y
    Thorac Cancer; 2020 Mar; 11(3):631-639. PubMed ID: 31943824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes for Esophageal Squamous Cell Carcinoma Treated with Curative Intent in a Western Cohort: Should Multimodal Therapy Be the Gold Standard?
    Sheil F; Donohoe CL; King S; O'Toole D; Cunningham M; Cuffe S; Ravi N; Reynolds JV
    World J Surg; 2018 May; 42(5):1485-1495. PubMed ID: 29075858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy.
    Tsai PC; Chien HC; Hsu PK; Hung JJ; Huang CS; Hsu WH; Hsu HS
    BMC Cancer; 2022 Jun; 22(1):637. PubMed ID: 35681112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy.
    Swisher SG; Wynn P; Putnam JB; Mosheim MB; Correa AM; Komaki RR; Ajani JA; Smythe WR; Vaporciyan AA; Roth JA; Walsh GL
    J Thorac Cardiovasc Surg; 2002 Jan; 123(1):175-83. PubMed ID: 11782772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
    Depypere L; Lerut T; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P; Nafteux P
    Dis Esophagus; 2017 Jan; 30(1):1-8. PubMed ID: 27704661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment strategies in recurrent esophageal or junctional cancer.
    Butter R; Lagarde SM; van Oijen MGH; Anderegg MCJ; Gisbertz SS; Meijer SL; Hulshof MCCM; Bergman JJGHM; van Berge Henegouwen MI; van Laarhoven HWM
    Dis Esophagus; 2017 Sep; 30(9):1-9. PubMed ID: 28859371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
    Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
    Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of esophageal carcinoma with curative intent: analysis of a single center experience.
    De Giacomo T; Trentino P; Venuta F; Tsagkaropoulos S; Berloco PB; Diso D; Francioni F
    J Cardiothorac Surg; 2013 Mar; 8():52. PubMed ID: 23509872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced Age is Not a Contraindication for Treatment With Curative Intent in Esophageal Cancer.
    Voncken FEM; van der Kaaij RT; Sikorska K; van Werkhoven E; van Dieren JM; Grootscholten C; Snaebjornsson P; van Sandick JW; Aleman BMP
    Am J Clin Oncol; 2018 Sep; 41(9):919-926. PubMed ID: 28763327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in Diagnosis, Treatment, and Outcome of Esophageal Cancer in a Regionalized Care System in Ontario, Canada.
    Habbous S; Yermakhanova O; Forster K; Holloway CMB; Darling G
    JAMA Netw Open; 2021 Sep; 4(9):e2126090. PubMed ID: 34546371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting early cancer-related deaths after curative esophagectomy for esophageal cancer.
    Matsumoto S; Takayama T; Wakatsuki K; Enomoto K; Tanaka T; Migita K; Ito M; Nakajima Y
    Am Surg; 2013 May; 79(5):528-33. PubMed ID: 23635590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of clinical T2N0M0 esophageal cancer.
    Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
    Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.